Urothelial malignancy--much promise but little progress

Editorial

R R Bahnson. J Urol. 1996 Jan.

. 1996 Jan;155(1):122.

doi: 10.1016/s0022-5347(01)66565-0.

No abstract available

Comment on

Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence.
Kriegmair M, Baumgartner R, Knüchel R, Stepp H, Hofstädter F, Hofstetter A. Kriegmair M, et al. J Urol. 1996 Jan;155(1):105-9; discussion 109-10. J Urol. 1996. PMID: 7490803
Pattern of metastases in relation to characteristics of primary tumor and treatment in patients with disseminated urothelial carcinoma.
Sengeløv L, Kamby C, von der Maase H. Sengeløv L, et al. J Urol. 1996 Jan;155(1):111-4. J Urol. 1996. PMID: 7490804
Postoperative radiation therapy in 26 patients with invasive transitional cell carcinoma of the upper urinary tract: no impact on survival?
Maulard-Durdux C, Dufour B, Hennequin C, Chrétien Y, Vignes B, Droz D, Delanian S, Housset M. Maulard-Durdux C, et al. J Urol. 1996 Jan;155(1):115-7. J Urol. 1996. PMID: 7490805 Clinical Trial.
Adjuvant methotrexate, vinblastine and cisplatin chemotherapy for invasive transitional cell carcinoma: Taiwan experience.
Wei CH, Hsieh RK, Chiou TJ, Chen KK, Chang LS, Chen PM. Wei CH, et al. J Urol. 1996 Jan;155(1):118-21. J Urol. 1996. PMID: 7490806 Clinical Trial.